Allogene Therapeutics Inc Earnings

The next earnings date for Allogene Therapeutics Inc is October 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Allogene Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
10/30/2025	$-0.23

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Allogene Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/13/2025	---	$-0.23	14.81%
05/12/2025	Before Market	$-0.28	31.71%
03/12/2025	Before Market	$-0.28	13.42%
11/07/2024	After Market	$-0.32	3.03%
08/07/2024	After Market	$-0.35	0.00%
05/13/2024	After Market	$-0.38	7.32%
03/14/2024	After Market	$-0.43	4.44%
11/02/2023	After Market	$-0.37	28.85%
08/02/2023	After Market	$-0.53	10.17%
05/03/2023	After Market	$-0.68	-9.68%
02/28/2023	After Market	$-0.66	5.71%
11/02/2022	After Market	$-0.58	9.38%
08/09/2022	After Market	$-0.52	14.75%
05/04/2022	After Market	$-0.56	3.45%
02/23/2022	After Market	$-0.54	10.00%
11/04/2021	After Market	$-0.57	-1.79%
08/04/2021	After Market	$-0.53	3.64%
05/05/2021	After Market	$-0.25	45.65%
02/25/2021	After Market	$-0.53	5.36%
11/04/2020	Before Market	$-0.52	3.70%
08/05/2020	Before Market	$-0.53	1.85%
05/06/2020	Before Market	$-0.50	13.79%
02/27/2020	Before Market	$-0.58	14.71%
11/05/2019	Before Market	$-0.50	7.41%
08/07/2019	Before Market	$-0.41	10.87%
05/07/2019	Before Market	$-0.32	25.58%
03/08/2019	Before Market	$-0.37	-42.31%
11/21/2018	After Market	$-10.71	-3,470.00%
08/29/2018	---	$-2.23	---

More About Allogene Therapeutics Inc

Website

https://allogene.com

Country

USA

Full Time Employees

226

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops, manufactures, and commercializes UCART19, an allogeneic anti-CD19 chimeric antigen receptor (CAR) T cell product candidate for the treatment of patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma. In addition, it provides clinical-stage products, such as ALLO-501, cema-cel, ALLO-316, ALLO-329, ALLO-715, and ALLO-605; DLL3 for the treatment of small cell lung cancer; Claudin 18.2 for the treatment of gastric and pancreatic cancer; and FLT3 for the treatment of acute myeloid leukemia. The company has license and collaboration agreements with Pfizer Inc., Servier, Cellectis S.A., and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.

“Allogene Therapeutics Inc Earnings” Can Refer to the Allogene Therapeutics Inc Earnings Date

Some people say “Allogene Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Allogene Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Allogene Therapeutics Inc Stock on the Earnings Date

If you own Allogene Therapeutics Inc stock (ALLO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Allogene Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Allogene Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Allogene Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Allogene Therapeutics Inc earnings or anything else related to the stock market.